Fillers and Diluents Segment has the Largest Share of Product in the South and Central America Pharmaceutical Excipients Market during 2020-2027
According to this research study titled “South and Central America Pharmaceutical Excipients Market to 2027 - COVID-19 Impact and Regional Analysis and Forecast by Product, Functionality, and Type of Formulation,” the market is expected to reach US$ 413.7 million by 2027 from US$ 305.3 million in 2019. The market is estimated to grow at a CAGR of 4.0% from 2020 to 2027. The report provides trends prevailing in the South and Central America Pharmaceutical excipients market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the surge in generics market and growth of the pharmaceutical market backed by multi-functional excipients are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the cost and time intensive drug development process.
The growing fear of COVID-19 infection transmission has mandated the development of new guidelines and recommendations by health authorities. The economic crises that have hit different parts of Latin America in recent years have threatened the progress of the pharmaceutical industry in some of the countries. In Argentina, the Federal Government has reduced formalities for Governmental purchase of medicines, medical devices and medical supplies. Companies involved in the manufacture, distribution and commercialization of the key supplies have to increase production to their maximum capacity and report to the Sanitary Regulatory Authority and the Ministry of Production, production plans as well as the amount of goods produced and sold and identify the buyers. Besides, the Brazilian Federal Health Agency (ANVISA) has issued several regulations providing exceptions to regulatory requirements for pharmaceutical products, medical supplies and medical devices related to COVID-19. Requirements for corporate permits for sanitizers and certain medical drugs and devices, as well as for the extraordinary acceptance of importation of products that are not registered in Brazil, have been relaxed under certain conditions.
The market for pharmaceutical excipients market is segmented into product, functionality, and type of formulation. Based on product, the pharmaceutical excipients market is segmented into organic chemicals, inorganic chemicals and other products. In 2019, the organic chemicals segment accounted for the largest share, moreover the same segment is expected to grow at a fastest CAGR during the forecast period. Organic chemicals are chemical compounds that contain carbon-hydrogen bonds and these can be found in natural or synthetic form. Most organic chemicals are carbon based, hence produced by plants or animals, whereas synthetic organic chemicals are produced through chemical reactions. Organically derived pharmaceuticals excipients include oleochemicals, carbohydrates, petrochemicals, proteins, povidones, acrylic polymers, mineral hydrocarbons, starch, cellulose, and others. The most commonly used oleo chemical-based pharmaceutical excipients are fatty alcohols, mineral stearates, glycerin, and lipids. The organic segment is expected to lead the market owing to the rise in the use of organic chemicals in various formulations in the pharmaceutical industry.
DuPont de Nemours, Inc., Roquette Frères, Ashland Global Holdings, Inc., BASF SE, Evonik Industries AG, Associated British Foods Plc, Archer Daniels Midland Company, Lubrizol Corporation, and Croda International Plc are among the leading companies in the South and Central America pharmaceutical excipients market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in October 2019, Ashland announces the launch of three new pharmaceutical solutions, Plasdone S630 Ultra, Benecel XR and XRF, and Viatel bioresorbable polymers. Ashland is expanding its portfolio to meet formulators growing needs and will introduce them at the upcoming tradeshows AAPS and CPhI.
The report segments the South and Central America Pharmaceutical Excipients market as follows:
By Product
By Functionality
By Type of Formulation
By Country
The growing fear of COVID-19 infection transmission has mandated the development of new guidelines and recommendations by health authorities. The economic crises that have hit different parts of Latin America in recent years have threatened the progress of the pharmaceutical industry in some of the countries. In Argentina, the Federal Government has reduced formalities for Governmental purchase of medicines, medical devices and medical supplies. Companies involved in the manufacture, distribution and commercialization of the key supplies have to increase production to their maximum capacity and report to the Sanitary Regulatory Authority and the Ministry of Production, production plans as well as the amount of goods produced and sold and identify the buyers. Besides, the Brazilian Federal Health Agency (ANVISA) has issued several regulations providing exceptions to regulatory requirements for pharmaceutical products, medical supplies and medical devices related to COVID-19. Requirements for corporate permits for sanitizers and certain medical drugs and devices, as well as for the extraordinary acceptance of importation of products that are not registered in Brazil, have been relaxed under certain conditions.
The market for pharmaceutical excipients market is segmented into product, functionality, and type of formulation. Based on product, the pharmaceutical excipients market is segmented into organic chemicals, inorganic chemicals and other products. In 2019, the organic chemicals segment accounted for the largest share, moreover the same segment is expected to grow at a fastest CAGR during the forecast period. Organic chemicals are chemical compounds that contain carbon-hydrogen bonds and these can be found in natural or synthetic form. Most organic chemicals are carbon based, hence produced by plants or animals, whereas synthetic organic chemicals are produced through chemical reactions. Organically derived pharmaceuticals excipients include oleochemicals, carbohydrates, petrochemicals, proteins, povidones, acrylic polymers, mineral hydrocarbons, starch, cellulose, and others. The most commonly used oleo chemical-based pharmaceutical excipients are fatty alcohols, mineral stearates, glycerin, and lipids. The organic segment is expected to lead the market owing to the rise in the use of organic chemicals in various formulations in the pharmaceutical industry.
DuPont de Nemours, Inc., Roquette Frères, Ashland Global Holdings, Inc., BASF SE, Evonik Industries AG, Associated British Foods Plc, Archer Daniels Midland Company, Lubrizol Corporation, and Croda International Plc are among the leading companies in the South and Central America pharmaceutical excipients market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in October 2019, Ashland announces the launch of three new pharmaceutical solutions, Plasdone S630 Ultra, Benecel XR and XRF, and Viatel bioresorbable polymers. Ashland is expanding its portfolio to meet formulators growing needs and will introduce them at the upcoming tradeshows AAPS and CPhI.
The report segments the South and Central America Pharmaceutical Excipients market as follows:
By Product
- Organic Chemicals
- Inorganic Chemicals
- Other Products
By Functionality
- Fillers & Diluents
- Suspending & Viscosity Agents
- Coating Agents
- Binders
- Preservatives
- Emulsifying Agents
- Other Functionalities
By Type of Formulation
- Oral Formulations
- Topical Formulations
- Parenteral Formulations
- Other Formulations
By Country
- South and Central America - Brazil
- Argentina
- Rest of South and Central America
Table of Contents
1. Introduction
3. Research Methodology
4. South and Central America Pharmaceutical Excipients Market - Market Landscape
5. South and Central America Pharmaceutical Excipients Market - Key Market Dynamics
6. Pharmaceutical Excipients Market - South and Central America Analysis
7. South and Central America Pharmaceutical Excipients Market Analysis and Forecasts To 2027 - By Product
8. South and Central America Pharmaceutical Excipients Market Analysis and Forecasts To 2027 - By Functionality
9. South and Central America Pharmaceutical Excipients Market Analysis and Forecasts to 2027- By Type of Formulation
10. Pharmaceutical Excipients Market Revenue and Forecasts to 2027 - Geographical Analysis
11. Impact Of COVID-19 Pandemic on South and Central America Pharmaceutical Excipients Market
12. Industry Landscape
13. Company Profiles
14. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- DuPont de Nemours, Inc.
- Ashland Global Holdings, Inc.
- BASF SE
- Evonik Industries AG
- Associated British Foods Plc
- Archer Daniels Midland Company
- Lubrizol Corporation
- Croda International Plc
- Roquette Frères
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 148 |
| Published | June 2021 |
| Forecast Period | 2019 - 2027 |
| Estimated Market Value ( USD | $ 305.3 Million |
| Forecasted Market Value ( USD | $ 413.7 Million |
| Compound Annual Growth Rate | 3.9% |
